AMETEK Posts Record Q2 Performance with Double‑Digit Growth in Sales and Orders Surge

AMETEK (NYSE: AME) reported record second‑quarter 2026 results, with net sales reaching $2.04 billion, a 15 percent increase year-over-year, and a notable surge in orders across both its operating segments.

Within its Electronic Instruments Group (EIG), the company achieved $1.32 billion in sales, up 14 percent compared to the same quarter in the prior year. The growth comprised roughly equal contributions from organic expansion and acquisitions. Orders into EIG jumped 23 percent, including 20 percent from organic demand, and the segment’s core operating margin improved by 40 basis points year-over-year, reaching 30.1 percent. Demand strength spanned the process instrumentation, aerospace, and power verticals, with semiconductor-related precision optics and metrology products particularly highlighted by management.

The Electromechanical Group (EMG) also delivered standout performance, with record sales of $723 million—a 17 percent increase from Q2 2025—driven by 15 percent organic growth plus a 2-point acquisition boost. Organic orders soared 35 percent. Operating income rose 32 percent to a record $191 million, and operating margins expanded by 290 basis points to 26.2 percent. EMG’s broad-based growth was anchored across aerospace, defense, medtech, and automation markets.

These results underscore AMETEK’s effective execution of its growth model, which is built on operational excellence, innovation, global expansion, and strategic acquisitions. The strong performance across both core operating groups reinforces the company’s diversified exposure to resilient markets.

Looking ahead, investors should monitor whether AMETEK provides updated guidance or commentary on sustained demand from the semiconductor and automation sectors in its upcoming earnings call or investor materials.

Verified live price: As of October 7, 2026, AMETEK shares traded at $248.62, reflecting a –0.86 percent change.